Product
Herpes Zoster Vaccine
Aliases
Herpes Zoster Vaccine GSK1437173A
2 clinical trials
1 indication
Indication
Herpes ZosterClinical trial
Efficacy, Safety and Immunogenicity of GSK Biologicals' HZ/su Vaccine GSK1437173A in a Phase IIIb, Open-label, Long-term Follow-up Study (ZOE-LTFU) of Studies 110390/113077 (ZOSTER-006/022) and Assessment of Additional Doses in Older AdultsStatus: Completed, Estimated PCD: 2023-06-28
Clinical trial
Long Term Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine 1437173A and Assessment of Re-vaccination With 2 Additional Doses, in Healthy Subjects Aged 60 Years of Age and OlderStatus: Completed, Estimated PCD: 2017-08-28